Mizuho Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $18.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target cut by investment analysts at Mizuho from $21.00 to $18.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the medical instruments supplier’s stock. Mizuho’s target price points to a potential upside of 17.92% from the stock’s current price.

Several other equities research analysts have also recently commented on the company. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Finally, Evercore ISI restated an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Stock Down 0.4 %

Shares of NASDAQ XRAY traded down $0.07 during midday trading on Thursday, hitting $15.27. The stock had a trading volume of 150,573 shares, compared to its average volume of 2,558,490. The company has a market cap of $3.04 billion, a P/E ratio of -7.37, a PEG ratio of 1.80 and a beta of 0.98. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average is $18.35 and its 200-day moving average is $20.97. DENTSPLY SIRONA has a 52 week low of $15.04 and a 52 week high of $34.16.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.52% of the stock is currently owned by insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in shares of DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock valued at $383,078,000 after buying an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after acquiring an additional 348,532 shares in the last quarter. Nuance Investments LLC lifted its position in DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock valued at $238,186,000 after acquiring an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock worth $219,018,000 after purchasing an additional 314,343 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.